Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2264491000001116 | Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2264501000001113 | Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Is a | Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator | EMA (European Medicines Agency) monitoring | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Is a | Zolgensma | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Has specific active ingredient | Onasemnogene abeparvovec | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Has dispensed dose form | Conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 2 x 5.5ml + 10 x 8.3ml vials | Has AMP | True | Zolgensma 20 tera vector genomes/ml (patient weight 16.6-17.0kg) solution for infusion 2 x 5.5ml + 10 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR